Viva Biotech Holdings (HKG:1873)
Hong Kong · Delayed Price · Currency is HKD 1.250
-0.070 (-5.30%)
May 28, 2026, 11:59 AM HKT
Viva Biotech Holdings Market Cap
Viva Biotech Holdings has a market cap or net worth of 2.77 billion as of May 27, 2026. Its market cap has decreased by -12.00% in one year.
Market Cap
2.77B
Enterprise Value
3.05B
Revenue
1.92B
Ranking
n/a
PE Ratio
13.18
Stock Price
1.25
Market Cap Chart
Since May 9, 2019, Viva Biotech Holdings's market cap has decreased from 6.63B to 2.77B, a decrease of -58.25%. That is a compound annual growth rate of -11.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 2.77B | -27.12% |
| Dec 31, 2025 | 3.80B | 109.02% |
| Dec 31, 2024 | 1.82B | -19.19% |
| Dec 29, 2023 | 2.25B | -32.91% |
| Dec 30, 2022 | 3.35B | -62.94% |
| Dec 31, 2021 | 9.04B | -48.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Luzhu Biotechnology | 3.88B |
| Shandong Boan Biotechnology | 3.77B |
| Mirxes Holding Company | 3.66B |
| Qyuns Therapeutics | 3.49B |
| BioDlink International Company | 3.45B |
| Clover Biopharmaceuticals | 3.32B |
| Jiangsu Recbio Technology | 3.18B |
| Medtide | 3.16B |